INS and obesity disorder: Activation of PPARα, a liver-predominant member of the peroxisome proliferator-activated receptors (PPARs), leads to reductions in triglyceride levels, ameliorates obesity, and inhibits liver fatty degeneration, thereby enhancing insulin sensitivity.